Pular para o conteúdo
Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA
ORPHA:90635CID-10 · H90.3CID-11 · AB50DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
AudiçãoInício infantilHerança AD
Sinônimos clínicos: Perda auditiva neurossensorial não-sindromática autossómica dominante tipo DFNA · Surdez neurossensorial não-sindromática autossómica dominante tipo DFNA · Surdez neurossensorial isolada autossómica dominante tipo DFNA · +1

Forma autossômica dominante de surdez não sindrômica.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A surdez neurossensorial rara tipo DFNA é uma condição genética hereditária que provoca perda da capacidade de ouvir, geralmente percebida a partir da infância. Essa forma de perda auditiva pode piorar com o passar do tempo e, em alguns casos, pode vir acompanhada de alterações nas plaquetas e quadros inflamatórios. A transmissão entre gerações segue o padrão autossômico dominante, significando que o risco de transmissão de um progenitor afetado para cada filho é de cinquenta por cento. Esta condição não consta na lista oficial de protocolos clínicos (PCDT) do Ministério da Saúde, não havendo remédio específico dispensado pelo SUS para reverter o gene alterado. O acompanhamento é feito com equipes especializadas na rede do SUS para reabilitação da audição e suporte aos sinais apresentados.

📋
Informacoes curadas por IA — podem conter imprecisoes

Forma autossômica dominante de surdez não sindrômica.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H90.3
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👂
Ouvidos
26 sintomas
🩸
Sangue
3 sintomas
👁️
Olhos
3 sintomas
🧠
Neurológico
3 sintomas
🫘
Rins
1 sintomas
🫃
Digestivo
1 sintomas

+ 16 sintomas em outras categorias

Características mais comuns

—
Deficiência auditiva neurossensorial progressiva
—
Trombocitopenia
—
Macrotrombocitopenia
—
Agregação plaquetária prejudicada
—
Hemorragia pós-parto
—
Partição incompleta da cóclea tipo II
53sintomas
Sem dados (53)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 53 características clínicas mais associadas, ordenadas por frequência.

Deficiência auditiva neurossensorial progressivaProgressive sensorineural hearing impairment
TrombocitopeniaThrombocytopenia
MacrotrombocitopeniaMacrothrombocytopenia
Agregação plaquetária prejudicadaImpaired platelet aggregation
Hemorragia pós-partoPost-partum hemorrhage

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

60 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

Curadoria gene-doença

fontes oficiais
LMX1A ATP2B2
LMX1A ATP2B2
SLC17A8Vesicular glutamate transporter 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
SLC-mediated transport of neurotransmitters
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 25

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA25 expression is variable in terms of onset and rate of progression, with an age-dependent penetrance resembling an early-onset presbycusis, or senile deafness, a progressive bilateral loss of hearing that occurs in the aged.

EXPRESSÃO TECIDUAL(Baixa expressão)
Intestino delgado
2.9 TPM
Hipotálamo
1.0 TPM
Brain Caudate basal ganglia
0.9 TPM
Cérebro - Amígdala
0.7 TPM
Hipocampo
0.6 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 25autosomal dominant nonsyndromic hearing loss
HGNC:20151UniProt:Q8NDX2
EPHA10Ephrin type-A receptor 10Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
EPH-ephrin mediated repulsion of cellsEPH-Ephrin signaling
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 88

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA88 is characterized by postlingual, progressive and severe hearing loss with tinnitus.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
33.1 TPM
Cólon transverso
14.7 TPM
Pituitária
11.3 TPM
Córtex cerebral
9.0 TPM
Brain Frontal Cortex BA9
7.7 TPM
OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 88
HGNC:HGNC:19987UniProt:Q5JZY3
SLC12A2Solute carrier family 12 member 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cation-coupled Chloride cotransporters
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 78

A form of non-syndromic deafness characterized by congenital, profound bilateral sensorineural hearing loss affecting all frequencies. Some patients may have mild motor delay early in life due to vestibular dysfunction. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
46.6 TPM
Glândula salivar
43.8 TPM
Brain Spinal cord cervical c-1
38.2 TPM
Intestino delgado
28.1 TPM
Esôfago - Muscular
27.6 TPM
OUTRAS DOENÇAS (3)
Kilquist syndromeDelpire-McNeill syndromehearing loss, autosomal dominant 78
HGNC:10911UniProt:P55011
DIAPH1Protein diaphanous homolog 1Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (8)
ERBB2 Regulates Cell MotilityRHO GTPases Activate ForminsRegulation of MITF-M dependent genes involved in invasionRHOF GTPase cycleRHOD GTPase cycle
MECANISMO DE DOENÇA

Deafness, autosomal dominant 1, with or without thrombocytopenia

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Patients may have mild thrombocytopenia and enlarged platelets, although most of DFNA1 affected individuals do not have significant bleeding tendencies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
99.8 TPM
Músculo esquelético
95.6 TPM
Pulmão
82.2 TPM
Esôfago - Mucosa
81.2 TPM
Skin Sun Exposed Lower leg
72.3 TPM
OUTRAS DOENÇAS (4)
progressive microcephaly-seizures-cortical blindness-developmental delay syndromeautosomal dominant nonsyndromic hearing loss 1Moyamoya diseaseDIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
HGNC:2876UniProt:O60610
ATOH1Transcription factor ATOH1Disease-causing germline mutation(s) inModerado
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 89

An autosomal dominant form of non-syndromic deafness characterized by progressive hearing loss, with onset at birth or early childhood.

OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 89
HGNC:HGNC:797UniProt:Q92858
PI4KBPhosphatidylinositol 4-kinase betaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Synthesis of PIPs at the Golgi membrane
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 87

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA87 is characterized by prelingual, profound sensorineural hearing loss with inner ear anomalies, including cochlear maldevelopment, absence of the osseous spiral lamina, and/or an enlarged vestibular aqueduct.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
100.6 TPM
Útero
97.3 TPM
Tireoide
95.0 TPM
Fallopian Tube
88.0 TPM
Cervix Endocervix
86.3 TPM
OUTRAS DOENÇAS (1)
hearing loss, autosomal dominant 87
HGNC:HGNC:8984UniProt:Q9UBF8
LMX1ALIM homeobox transcription factor 1-alphaDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 7

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA7 is a progressive form with highly variable age at onset and severity, even within families. The age at onset ranges from congenital to mid-adulthood.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
2.9 TPM
Pituitária
2.4 TPM
Tecido adiposo
0.9 TPM
Cervix Ectocervix
0.6 TPM
Esôfago - Junção
0.5 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss 7
HGNC:HGNC:6653UniProt:Q8TE12
RESTRE1-silencing transcription factorDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
Regulation of PTEN gene transcriptionPotential therapeutics for SARSHDACs deacetylate histonesNGF-stimulated transcriptionRegulation of NPAS4 gene transcription
MECANISMO DE DOENÇA

Wilms tumor 6

A pediatric malignancy of kidney, and the most common childhood abdominal malignancy. It is caused by the uncontrolled multiplication of renal stem, stromal, and epithelial cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
18.7 TPM
Testículo
16.2 TPM
Linfócitos
15.0 TPM
Nervo tibial
14.5 TPM
Ovário
13.4 TPM
OUTRAS DOENÇAS (5)
fibromatosis, gingival, 5autosomal dominant nonsyndromic hearing loss 27hereditary gingival fibromatosiskidney Wilms tumor
HGNC:9966UniProt:Q13127
MYO3AMyosin-IIIaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 30

A form of non-syndromic deafness characterized by bilateral progressive hearing loss, which first affects the high frequencies. Hearing loss begins in the second decade, and by age 50 is severe in high and middle frequencies and moderate at low frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
6.3 TPM
Artéria tibial
2.0 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
Brain Caudate basal ganglia
0.7 TPM
Pituitária
0.6 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 90autosomal recessive nonsyndromic hearing loss 30hearing loss, autosomal recessive
HGNC:7601UniProt:Q8NEV4
RIPOR2Rho family-interacting cell polarization regulator 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 104

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 21autosomal recessive nonsyndromic hearing loss 104hearing loss, autosomal recessive
HGNC:13872UniProt:Q9Y4F9
GREB1LGREB1-like proteinDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Renal hypodysplasia/aplasia 3

A severe, autosomal dominant disease encompassing a spectrum of kidney development defects. Clinical manifestations are highly variable and include bilateral or unilateral renal agenesis, renal aplasia, hypoplasia, (cystic) dysplasia, severe obstructive uropathy, and vesicoureteral reflux. Bilateral renal agenesis is almost invariably fatal in utero or in the perinatal period. Unilateral renal agenesis can lead to future health issues including end-stage renal disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fallopian Tube
8.7 TPM
Tireoide
7.4 TPM
Testículo
6.8 TPM
Ovário
6.4 TPM
Aorta
4.6 TPM
OUTRAS DOENÇAS (4)
hearing loss, autosomal dominant 80renal hypodysplasia/aplasia 3bilateral renal agenesisrenal agenesis, unilateral
HGNC:31042UniProt:Q9C091
GJB2Gap junction beta-2 proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Oligomerization of connexins into connexonsTransport of connexins along the secretory pathwayTransport of connexons to the plasma membrane
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 1A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
1032.4 TPM
Vagina
934.9 TPM
Skin Not Sun Exposed Suprapubic
76.3 TPM
Skin Sun Exposed Lower leg
75.7 TPM
Glândula salivar
21.6 TPM
OUTRAS DOENÇAS (12)
palmoplantar keratoderma-deafness syndromeichthyosis, hystrix-like, with hearing losskeratoderma hereditarium mutilansautosomal dominant keratitis-ichthyosis-hearing loss syndrome
HGNC:4284UniProt:P29033
USP48Ubiquitin carboxyl-terminal hydrolase 48Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Ub-specific processing proteases
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 85

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA85 is characterized by progressive hearing loss, with onset in childhood or young adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
68.8 TPM
Cérebro - Hemisfério cerebelar
55.8 TPM
Cerebelo
55.3 TPM
Ovário
36.8 TPM
Glândula adrenal
35.5 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 85autosomal dominant nonsyndromic hearing lossCushing disease due to pituitary adenoma
HGNC:18533UniProt:Q86UV5
DMXL2DmX-like protein 2Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Polyendocrine-polyneuropathy syndrome

A progressive endocrine and neurodevelopmental disorder manifesting early in childhood with growth retardation and recurrent episodes of profound asymptomatic hypoglycemia. PEPNS is characterized by central hypothyroidism, hypogonadotropic hypogonadism, incomplete puberty, progressive non-autoimmune insulin-dependent diabetes mellitus, peripheral demyelinating sensorimotor polyneuropathy, and cerebellar and pyramidal signs.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
22.0 TPM
Cerebelo
20.8 TPM
Pituitária
16.6 TPM
Pulmão
14.8 TPM
Testículo
13.9 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 81polyendocrine-polyneuropathy syndromehearing loss, autosomal dominant 71early-infantile DEE
HGNC:2938UniProt:Q8TDJ6
TRRAPTransformation/transcription domain-associated proteinDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Formation of the beta-catenin:TCF transactivating complexHATs acetylate histonesUb-specific processing proteases
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
28.7 TPM
Pituitária
27.2 TPM
Testículo
25.9 TPM
Fibroblastos
25.3 TPM
Cerebelo
24.8 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 75developmental delay with or without dysmorphic facies and autismautosomal dominant nonsyndromic hearing loss
HGNC:12347UniProt:Q9Y4A5
KITLGKit ligandDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Signaling by SCF-KIT
MECANISMO DE DOENÇA

Hyperpigmentation with or without hypopigmentation, familial progressive

A disorder characterized by hyperpigmented patches in the skin, present in early infancy and increasing in size and number with age. Hyperpigmentation has variable intensity, and sometimes is associated with cafe-au-lait macules and larger hypopigmented ash-leaf macules.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
65.5 TPM
Esôfago - Muscular
42.9 TPM
Cólon sigmoide
35.5 TPM
Esôfago - Junção
34.5 TPM
Pulmão
33.7 TPM
OUTRAS DOENÇAS (8)
hyperpigmentation with or without hypopigmentation, familial progressiveWaardenburg syndrome, IIa 2Fautosomal dominant nonsyndromic hearing loss 69familial progressive hyperpigmentation
HGNC:6343UniProt:P21583
CRYMKetimine reductase mu-crystallinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Lysine catabolism
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 40

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
153.7 TPM
Cérebro - Hemisfério cerebelar
150.5 TPM
Cerebelo
121.9 TPM
Brain Frontal Cortex BA9
90.3 TPM
Córtex cerebral
70.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 40autosomal dominant nonsyndromic hearing loss
HGNC:2418UniProt:Q14894
CCDC50Coiled-coil domain-containing protein 50Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 44

A form of non-syndromic deafness characterized by initially moderate hearing loss that affects mainly low to mid frequencies. Later, it progresses to involve all the frequencies and leads to a profound hearing loss by the 6th decade.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 44autosomal dominant nonsyndromic hearing loss
HGNC:18111UniProt:Q8IVM0
DIABLODiablo IAP-binding mitochondrial proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes SMAC (DIABLO) binds to IAPs SMAC, XIAP-regulated apoptotic responseRelease of apoptotic factors from the mitochondriaRegulation of the apoptosome activity
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 64

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
33.2 TPM
Pituitária
18.1 TPM
Fibroblastos
15.9 TPM
Linfócitos
15.9 TPM
Ovário
13.0 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 64autosomal dominant nonsyndromic hearing loss
HGNC:21528UniProt:Q9NR28
HOMER2Homer protein homolog 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Neurexins and neuroligins
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 68

A form of non-syndromic sensorineural hearing loss with postlingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Pâncreas
24.0 TPM
Glândula salivar
20.2 TPM
Próstata
16.3 TPM
Skin Sun Exposed Lower leg
15.1 TPM
Estômago
13.8 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 68autosomal dominant nonsyndromic hearing loss
HGNC:17513UniProt:Q9NSB8
SLC44A4Choline transporter-like protein 4Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Synthesis of PCSLC-mediated bile acid transport
EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
148.6 TPM
Cólon transverso
147.1 TPM
Intestino delgado
93.0 TPM
Estômago
83.9 TPM
Glândula salivar
52.5 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 72autosomal dominant nonsyndromic hearing loss
HGNC:13941UniProt:Q53GD3
POU4F3POU domain, class 4, transcription factor 3Disease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 15

A form of non-syndromic hearing loss with variable phenotype in terms of age at onset, levels of progression, and shape of audiograms.

EXPRESSÃO TECIDUAL(Não detectado)
Nervo tibial
0.2 TPM
Aorta
0.2 TPM
Artéria tibial
0.2 TPM
Skin Sun Exposed Lower leg
0.2 TPM
Brain Spinal cord cervical c-1
0.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 15autosomal dominant nonsyndromic hearing loss
HGNC:9220UniProt:Q15319
MYH9Myosin-9Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss

An autosomal dominant disorder characterized by thrombocytopenia, giant platelets and Dohle body-like inclusions in peripheral blood leukocytes with variable ultrastructural appearance. Some affected individuals lack leukocyte inclusion bodies on classic staining of peripheral blood smears. Alport syndrome-like features of nephritis, hearing loss, and eye abnormalities are present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
1592.3 TPM
Artéria tibial
1091.7 TPM
Útero
820.6 TPM
Artéria coronária
818.3 TPM
Pulmão
601.2 TPM
OUTRAS DOENÇAS (4)
autosomal dominant nonsyndromic hearing loss 17macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing lossnodular fasciitisautosomal dominant nonsyndromic hearing loss
HGNC:7579UniProt:P35579
GSDMEGasdermin-EDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 5

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 5autosomal dominant nonsyndromic hearing loss
HGNC:2810UniProt:O60443
GJB6Gap junction beta-6 proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Ectodermal dysplasia 2, Clouston type

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD2 is an autosomal dominant condition characterized by atrichosis, nail hypoplasia and deformities, hyperpigmentation of the skin, normal teeth, normal sweat and sebaceous gland function. Palmoplantar hyperkeratosis is a frequent feature. Hearing impairment has been detected in few cases.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
199.5 TPM
Vagina
198.2 TPM
Skin Sun Exposed Lower leg
51.2 TPM
Córtex cerebral
51.0 TPM
Skin Not Sun Exposed Suprapubic
48.1 TPM
OUTRAS DOENÇAS (7)
autosomal recessive nonsyndromic hearing loss 1Bautosomal recessive nonsyndromic hearing loss 1AClouston syndromeautosomal dominant nonsyndromic hearing loss 3B
HGNC:4288UniProt:O95452
WFS1WolframinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Wolfram syndrome 1

A rare disorder characterized by juvenile-onset insulin-dependent diabetes mellitus with optic atrophy. Other manifestations include diabetes insipidus, sensorineural deafness, dementia, psychiatric illnesses.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
209.9 TPM
Útero
191.1 TPM
Aorta
160.6 TPM
Fallopian Tube
157.4 TPM
Artéria tibial
151.6 TPM
OUTRAS DOENÇAS (8)
Wolfram syndrome 1Wolfram-like syndromeautosomal dominant nonsyndromic hearing loss 6cataract 41
HGNC:12762UniProt:O76024
TECTAAlpha-tectorinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Post-translational modification: synthesis of GPI-anchored proteins
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 12

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
3.3 TPM
Pituitária
3.0 TPM
Cérebro - Hemisfério cerebelar
2.9 TPM
Testículo
2.7 TPM
Tireoide
2.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 12autosomal recessive nonsyndromic hearing loss 21nonsyndromic genetic hearing losshearing loss, autosomal recessive
HGNC:11720UniProt:O75443
MCM2DNA replication licensing factor MCM2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Activation of ATR in response to replication stressActivation of the pre-replicative complexOrc1 removal from chromatinUnwinding of DNAAssembly of the pre-replicative complex
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
137.4 TPM
Testículo
24.9 TPM
Fibroblastos
22.0 TPM
Esôfago - Mucosa
12.7 TPM
Baço
12.3 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 70autosomal dominant nonsyndromic hearing loss
HGNC:6944UniProt:P49736
TNCTenascinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 56

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA56 is characterized by progressive hearing impairment with postlingual onset.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
351.7 TPM
Cólon sigmoide
199.3 TPM
Fibroblastos
99.0 TPM
Rim - Medula
83.0 TPM
Artéria coronária
77.4 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 56autosomal dominant nonsyndromic hearing loss
HGNC:5318UniProt:P24821
ACTG1Actin, cytoplasmic 2Disease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (10)
Paradoxical activation of RAF signaling by kinase inactive BRAFSignaling by moderate kinase activity BRAF mutantsSignaling by high-kinase activity BRAF mutantsSignaling downstream of RAS mutantsMAP2K and MAPK activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 20

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (6)
autosomal dominant nonsyndromic hearing loss 20Baraitser-winter syndrome 2Baraitser-Winter cerebrofrontofacial syndromecoloboma of iris
HGNC:144UniProt:P63261
EYA4Protein phosphatase EYA4Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 10

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
16.8 TPM
Próstata
5.8 TPM
Pituitária
5.6 TPM
Cervix Endocervix
5.1 TPM
Cervix Ectocervix
3.9 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 10dilated cardiomyopathy 1Jautosomal dominant nonsyndromic hearing loss
HGNC:3522UniProt:O95677
MIR96Disease-causing germline mutation(s) inDesconhecido
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 50autosomal dominant nonsyndromic hearing loss
HGNC:31648
MYO1AUnconventional myosin-IaCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Diarrhea 15, congenital

An autosomal recessive disorder characterized by severe diarrhea manifesting in infancy and resolving by the second year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
103.4 TPM
Cólon transverso
51.6 TPM
Brain Spinal cord cervical c-1
9.6 TPM
Estômago
4.3 TPM
Testículo
2.7 TPM
OUTRAS DOENÇAS (2)
diarrhea 15, congenitalautosomal dominant nonsyndromic hearing loss
HGNC:7595UniProt:Q9UBC5
COL11A1Collagen alpha-1(XI) chainDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Stickler syndrome 2

An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable.

OUTRAS DOENÇAS (8)
Marshall syndromeStickler syndrome type 2hearing loss, autosomal dominant 37fibrochondrogenesis 1
HGNC:2186UniProt:P12107
SSBP1Single-stranded DNA-binding protein, mitochondrialMajor susceptibility factor inTolerante
VIAS BIOLÓGICAS (3)
Strand-asynchronous mitochondrial DNA replicationMitochondrial protein degradationTranscriptional activation of mitochondrial biogenesis
MECANISMO DE DOENÇA

Optic atrophy 13 with retinal and foveal abnormalities

An autosomal dominant disease characterized by visual impairment in association with bilateral optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. Many OPA13 patients also exhibit retinal pigmentary defects, attenuated retinal vasculature, macular dystrophy, and foveopathy. Some patients may develop additional systemic features, including sensorineural deafness and progressive nephropathy resulting in renal failure.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
151.8 TPM
Fibroblastos
127.4 TPM
Artéria tibial
80.8 TPM
Testículo
78.2 TPM
Ovário
74.8 TPM
OUTRAS DOENÇAS (2)
optic atrophy 13 with retinal and foveal abnormalitiesautosomal dominant nonsyndromic hearing loss
HGNC:11317UniProt:Q04837
ABCC1Multidrug resistance-associated protein 1Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (8)
Transport of RCbl within the bodyCytoprotection by HMOX1Heme degradationSynthesis of Leukotrienes (LT) and Eoxins (EX)Sphingolipid de novo biosynthesis
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 77

A form of non-syndromic deafness characterized by adult onset of bilateral, postlingual, mild-to-severe sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 77autosomal dominant nonsyndromic hearing loss
HGNC:51UniProt:P33527
PLS1Plastin-1Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 76

A form of non-syndromic deafness characterized by mild to profound sensorineural hearing loss and variable age at onset. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
34.2 TPM
Cólon transverso
31.1 TPM
Pituitária
9.8 TPM
Glândula salivar
9.4 TPM
Esôfago - Mucosa
9.2 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 76autosomal dominant nonsyndromic hearing loss
HGNC:9090UniProt:Q14651
TMC1Transmembrane channel-like protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 36

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA36 is a bilateral hearing loss, and begins at 5-10 years of age. It progresses to profound deafness within 10-15 years.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.4 TPM
Esôfago - Mucosa
0.7 TPM
Brain Spinal cord cervical c-1
0.6 TPM
Próstata
0.4 TPM
Vagina
0.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 7autosomal dominant nonsyndromic hearing loss 36autosomal dominant nonsyndromic hearing losshearing loss, autosomal recessive
HGNC:16513UniProt:Q8TDI8
TJP2Tight junction protein 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Signaling by Hippo
MECANISMO DE DOENÇA

Hypercholanemia, familial, 1

A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
103.6 TPM
Nervo tibial
85.5 TPM
Pulmão
84.2 TPM
Tecido adiposo
81.3 TPM
Tireoide
80.0 TPM
OUTRAS DOENÇAS (3)
cholestasis, progressive familial intrahepatic, 4hypercholanemia, familial 1autosomal dominant nonsyndromic hearing loss
HGNC:11828UniProt:Q9UDY2
MYO7AUnconventional myosin-VIIaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1B

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.8 TPM
Glândula adrenal
40.7 TPM
Pituitária
27.6 TPM
Baço
20.4 TPM
Fígado
12.7 TPM
OUTRAS DOENÇAS (9)
autosomal dominant nonsyndromic hearing loss 11autosomal recessive nonsyndromic hearing loss 2Usher syndrome type 1Bnonsyndromic genetic hearing loss
HGNC:7606UniProt:Q13402
TBC1D24TBC1 domain family member 24Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
TBC/RABGAPs
MECANISMO DE DOENÇA

Familial infantile myoclonic epilepsy

A subtype of idiopathic epilepsy starting in early infancy and manifesting as myoclonic seizures, febrile convulsions, and tonic-clonic seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
27.8 TPM
Cérebro - Hemisfério cerebelar
26.6 TPM
Brain Frontal Cortex BA9
11.4 TPM
Córtex cerebral
11.2 TPM
Pituitária
9.4 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (11)
familial infantile myoclonic epilepsyrolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndromeautosomal dominant nonsyndromic hearing loss 65autosomal recessive nonsyndromic hearing loss 86
HGNC:29203UniProt:Q9ULP9
KCNQ4Potassium voltage-gated channel subfamily KQT member 4Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
Voltage gated Potassium channelsSensory processing of sound by inner hair cells of the cochleaSensory processing of sound by outer hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 2A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
34.4 TPM
Esôfago - Muscular
29.5 TPM
Esôfago - Junção
26.7 TPM
Artéria tibial
20.7 TPM
Útero
19.5 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 2Anonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
HGNC:6298UniProt:P56696
MYH14Myosin-14Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (6)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
109.7 TPM
Músculo esquelético
106.9 TPM
Skin Not Sun Exposed Suprapubic
97.8 TPM
Esôfago - Mucosa
66.6 TPM
Tireoide
53.2 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 4Aperipheral neuropathy-myopathy-hoarseness-hearing loss syndromeautosomal dominant nonsyndromic hearing loss
HGNC:23212UniProt:Q7Z406
CD164Sialomucin core protein 24Disease-causing germline mutation(s) inModerado
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 66

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 66autosomal dominant nonsyndromic hearing loss
HGNC:1632UniProt:Q04900
COL11A2Collagen alpha-2(XI) chainDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Otospondylomegaepiphyseal dysplasia, autosomal dominant

An autosomal dominant form of otospondylomegaepiphyseal dysplasia, a disorder characterized by sensorineural deafness, enlarged epiphyses, mild platyspondyly, and disproportionate shortness of the limbs. Total body length is normal. Typical facial features are mid-face hypoplasia, short upturned nose and depressed nasal bridge. Most patients have Pierre Robin sequence including an opening in the roof of the mouth (cleft palate) and a small lower jaw (micrognathia). Ocular symptoms are absent. Some patients have early-onset osteoarthritis.

OUTRAS DOENÇAS (9)
otospondylomegaepiphyseal dysplasia, autosomal dominantotospondylomegaepiphyseal dysplasia, autosomal recessiveautosomal dominant nonsyndromic hearing loss 13autosomal recessive nonsyndromic hearing loss 53
HGNC:2187UniProt:P13942
GRHL2Grainyhead-like protein 2 homologDisease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 28

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
41.4 TPM
Skin Sun Exposed Lower leg
39.8 TPM
Próstata
34.7 TPM
Esôfago - Mucosa
33.1 TPM
Glândula salivar
24.8 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 28corneal dystrophy, posterior polymorphous, 4nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeposterior polymorphous corneal dystrophy
HGNC:2799UniProt:Q6ISB3
MYO6Unconventional myosin-VIDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (4)
Trafficking of AMPA receptorsRHOU GTPase cycleRHOBTB2 GTPase cycleRHOBTB1 GTPase cycle
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 22

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
31.4 TPM
Rim - Medula
29.8 TPM
Esôfago - Mucosa
29.7 TPM
Cérebro - Hemisfério cerebelar
28.1 TPM
Cerebelo
28.0 TPM
OUTRAS DOENÇAS (6)
autosomal recessive nonsyndromic hearing loss 37autosomal dominant nonsyndromic hearing loss 22nonsyndromic genetic hearing lossprogressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
HGNC:7605UniProt:Q9UM54
MYO1CUnconventional myosin-IcDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (5)
Regulation of actin dynamics for phagocytic cup formationFCGR3A-mediated phagocytosisSensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochleaTranslocation of SLC2A4 (GLUT4) to the plasma membrane
EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
213.8 TPM
Tecido adiposo
207.3 TPM
Aorta
184.2 TPM
Nervo tibial
182.3 TPM
Esôfago - Muscular
174.3 TPM
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss
HGNC:7597UniProt:O00159
OSBPL2Oxysterol-binding protein-related protein 2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Synthesis of bile acids and bile salts
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 67

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
53.2 TPM
Cerebelo
52.3 TPM
Skin Not Sun Exposed Suprapubic
41.8 TPM
Skin Sun Exposed Lower leg
40.4 TPM
Vagina
32.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 67autosomal dominant nonsyndromic hearing loss
HGNC:15761UniProt:Q9H1P3
GJB3Gap junction beta-3 proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 1

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
184.0 TPM
Skin Not Sun Exposed Suprapubic
182.9 TPM
Esôfago - Mucosa
87.3 TPM
Vagina
41.6 TPM
Próstata
4.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (7)
autosomal dominant nonsyndromic hearing loss 2Bautosomal recessive nonsyndromic hearing loss 1Aerythrokeratodermia variabilis et progressiva 1hearing loss, autosomal recessive
HGNC:4285UniProt:O75712
P2RX2P2X purinoceptor 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Elevation of cytosolic Ca2+ levelsPlatelet homeostasis
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 41

A form of non-syndromic deafness characterized by onset of progressive sensorineural hearing loss usually in the second decade. The hearing loss is severe and ultimately affects all frequencies. Exposure to noise exacerbates the hearing loss, particularly at high frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Próstata
17.3 TPM
Esôfago - Junção
12.0 TPM
Esôfago - Muscular
8.6 TPM
Pulmão
6.3 TPM
Fallopian Tube
5.1 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 41autosomal dominant nonsyndromic hearing loss
HGNC:15459UniProt:Q9UBL9
DIAPH3Protein diaphanous homolog 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (10)
RHO GTPases Activate ForminsRAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOF GTPase cycle
MECANISMO DE DOENÇA

Auditory neuropathy, autosomal dominant 1

A form of sensorineural hearing loss with absent or severely abnormal auditory brainstem response, in the presence of normal cochlear outer hair cell function and normal otoacoustic emissions. Auditory neuropathies result from a lesion in the area including the inner hair cells, connections between the inner hair cells and the cochlear branch of the auditory nerve, the auditory nerve itself and auditory pathways of the brainstem. Affected individuals typically respond to sound but have difficulties in speech discrimination.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
20.9 TPM
Linfócitos
15.0 TPM
Fibroblastos
11.9 TPM
Esôfago - Mucosa
2.7 TPM
Aorta
2.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant auditory neuropathy 1autosomal dominant nonsyndromic hearing loss
HGNC:15480UniProt:Q9NSV4
ATP11APhospholipid-transporting ATPase IHDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 84

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA84 is characterized by slowly progressive, postlingual hearing loss.

OUTRAS DOENÇAS (5)
leukodystrophy, hypomyelinating, 24hearing loss, autosomal dominant 84auditory neuropathy, autosomal dominant 2idiopathic pulmonary fibrosis
HGNC:13552UniProt:P98196
PTPRQPhosphatidylinositol phosphatase PTPRQDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 84A

A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.0 TPM
Fibroblastos
4.0 TPM
Rim - Córtex
3.1 TPM
Adipose Visceral Omentum
2.5 TPM
Pulmão
1.5 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 84Ahearing loss, autosomal dominant 73hearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:9679UniProt:Q9UMZ3
SIX1Homeobox protein SIX1Disease-causing germline mutation(s) inModerado
VIAS BIOLÓGICAS (1)
Formation of the ureteric bud
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 23

A form of non-syndromic deafness characterized by prelingual, bilateral, symmetric hearing loss with a conductive component present in some but not all patients.

EXPRESSÃO TECIDUAL(Tecido-específico)
Pituitária
30.7 TPM
Músculo esquelético
30.5 TPM
Fibroblastos
14.8 TPM
Próstata
12.4 TPM
Glândula salivar
10.5 TPM
OUTRAS DOENÇAS (5)
branchiootic syndrome 3autosomal dominant nonsyndromic hearing loss 23branchiootic syndromebranchio-oto-renal syndrome
HGNC:10887UniProt:Q15475
COCHCochlinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 9

A form of non-syndromic hearing loss characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Hearing loss is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers.

OUTRAS DOENÇAS (4)
autosomal dominant nonsyndromic hearing loss 9hearing loss, autosomal recessive 110nonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
HGNC:2180UniProt:O43405
CENPPCentromere protein PDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (6)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss
HGNC:32933UniProt:Q6IPU0
CEACAM16Cell adhesion molecule CEACAM16Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4B

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
hearing loss, autosomal recessive 113autosomal dominant nonsyndromic hearing loss 4Bhearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:31948UniProt:Q2WEN9
MAP1BMicrotubule-associated protein 1BDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
RSV-host interactions
MECANISMO DE DOENÇA

Periventricular nodular heterotopia 9

A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH9 is an autosomal dominant disorder with incomplete penetrance, characterized by impaired intellectual development, cognitive defects, learning disabilities, and behavior abnormalities. Some patients develop seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
262.6 TPM
Cerebelo
227.2 TPM
Brain Frontal Cortex BA9
180.1 TPM
Aorta
169.2 TPM
Brain Spinal cord cervical c-1
158.9 TPM
OUTRAS DOENÇAS (4)
periventricular nodular heterotopia 9hearing loss, autosomal dominant 83periventricular nodular heterotopiaautosomal dominant nonsyndromic hearing loss
HGNC:6836UniProt:P46821
PDE1CDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Cam-PDE 1 activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 74

A form of non-syndromic deafness characterized by progressive, postlingual hearing loss with onset in the third decade of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
14.4 TPM
Brain Spinal cord cervical c-1
13.3 TPM
Fallopian Tube
12.2 TPM
Coração - Átrio
9.9 TPM
Bladder
8.4 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 74autosomal dominant nonsyndromic hearing loss
HGNC:8776UniProt:Q14123

Variantes genéticas (ClinVar)

203 variantes patogênicas registradas no ClinVar.

🧬 SLC17A8: NM_139319.3(SLC17A8):c.578G>T (p.Gly193Val) ()
🧬 SLC17A8: GRCh37/hg19 12q23.1-24.33(chr12:99532287-133777902)x3 ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.869G>T (p.Ser290Ile) ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.1651A>G (p.Thr551Ala) ()
🧬 SLC17A8: NM_139319.3(SLC17A8):c.83C>G (p.Ser28Cys) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

142 vias biológicas associadas aos genes desta condição.

SLC-mediated transport of neurotransmitters Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) Sensory processing of sound by inner hair cells of the cochlea EPH-Ephrin signaling EPHA-mediated growth cone collapse EPH-ephrin mediated repulsion of cells Cation-coupled Chloride cotransporters RHO GTPases Activate Formins ERBB2 Regulates Cell Motility Neutrophil degranulation RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle RHOD GTPase cycle RHOF GTPase cycle Regulation of MITF-M dependent genes involved in invasion Synthesis of PIPs at the Golgi membrane HDACs deacetylate histones Regulation of PTEN gene transcription NGF-stimulated transcription Potential therapeutics for SARS Regulation of NPAS4 gene transcription Sensory processing of sound by outer hair cells of the cochlea Oligomerization of connexins into connexons Transport of connexins along the secretory pathway Gap junction assembly Transport of connexons to the plasma membrane Ub-specific processing proteases Formation of the beta-catenin:TCF transactivating complex HATs acetylate histones PIP3 activates AKT signaling Signaling by SCF-KIT Regulation of KIT signaling Constitutive Signaling by Aberrant PI3K in Cancer RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Transcriptional and post-translational regulation of MITF-M expression and activity Lysine catabolism SMAC (<span class="highlighting" >DIABLO</span>) binds to IAPs SMAC(<span class="highlighting" >DIABLO</span>)-mediated dissociation of IAP:caspase complexes Release of apoptotic factors from the mitochondria Apoptotic factor-mediated response Neurexins and neuroligins Synthesis of PC SLC-mediated bile acid transport Translocation of SLC2A4 (GLUT4) to the plasma membrane Regulation of actin dynamics for phagocytic cup formation Sema4D induced cell migration and growth-cone collapse RHO GTPases activate PKNs RHO GTPases activate CIT RHO GTPases Activate ROCKs RHO GTPases activate PAKs CD163 mediating an anti-inflammatory response FCGR3A-mediated phagocytosis Signaling by ALK fusions and activated point mutants Pyroptosis Regulation of TLR by endogenous ligand Defective pyroptosis XBP1(S) activates chaperone genes Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Post-translational modification: synthesis of GPI-anchored proteins Unwinding of DNA Switching of origins to a post-replicative state Assembly of the pre-replicative complex CDC6 association with the ORC:origin complex G1/S-Specific Transcription Integrin cell surface interactions Syndecan interactions ECM proteoglycans Gap junction degradation Formation of annular gap junctions EPHB-mediated forward signaling Adherens junctions interactions Recycling pathway of L1 VEGFA-VEGFR2 Pathway Interaction between L1 and Ankyrins Cell-extracellular matrix interactions RHO GTPases activate IQGAPs RHO GTPases Activate WASPs and WAVEs MAP2K and MAPK activation Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF1 fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Clathrin-mediated endocytosis RHOBTB2 GTPase cycle Signaling downstream of RAS mutants Signaling by RAF1 mutants Regulation of CDH1 Function Formation of the dystrophin-glycoprotein complex (DGC) GBP-mediated host defense Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Collagen degradation Collagen biosynthesis and modifying enzymes Assembly of collagen fibrils and other multimeric structures Non-integrin membrane-ECM interactions MET activates PTK2 signaling Collagen chain trimerization Developmental Lineage of Pancreatic Ductal Cells Transcriptional activation of mitochondrial biogenesis Mitochondrial protein degradation Strand-asynchronous mitochondrial DNA replication Sphingolipid de novo biosynthesis Heme degradation Synthesis of Leukotrienes (LT) and Eoxins (EX) ABC-family proteins mediated transport Cytoprotection by HMOX1 Paracetamol ADME Transport of RCbl within the body NFE2L2 regulating MDR associated enzymes Signaling by Hippo Apoptotic cleavage of cell adhesion proteins The canonical retinoid cycle in rods (twilight vision) TBC/RABGAPs Voltage gated Potassium channels Positive Regulation of CDH1 Gene Transcription Trafficking of AMPA receptors RHOU GTPase cycle RHOBTB1 GTPase cycle B-WICH complex positively regulates rRNA expression Synthesis of bile acids and bile salts Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin Elevation of cytosolic Ca2+ levels Platelet homeostasis CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOQ GTPase cycle RHOG GTPase cycle RHOJ GTPase cycle RAC3 GTPase cycle Ion transport by P-type ATPases Formation of the ureteric bud Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion Deposition of new CENPA-containing nucleosomes at the centromere Mitotic Prometaphase EML4 and NUDC in mitotic spindle formation RSV-host interactions Cam-PDE 1 activation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma forma genética e rara de surdez neurossensorial de herança autossômica dominante. Ela se manifesta tipicamente com perda da audição de início na infância e progressão ao longo da vida.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

5 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:90635
    Orphanet
  2. GARD:16791
    GARD (NIH)
  3. Q18553309
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/surdez-neurossensorial-nao-sindromica-rara-autossomica-dominante-tipo-dfna

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Surdez neurossensorial não-sindrômica rara autossômica dominante tipo DFNA

ORPHA:90635 · MONDO:0019587
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
H90.3 · Perda de audição bilateral neuro-sensorial
CID-11
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4539881
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara